Skip to main content
Erschienen in: Drugs & Aging 2/2020

01.02.2020 | Systematic Review

Interventions to Reduce Adverse Drug Event-Related Outcomes in Older Adults: A Systematic Review and Meta-analysis

verfasst von: Sarah Tecklenborg, Catherine Byrne, Caitriona Cahir, Lamorna Brown, Kathleen Bennett

Erschienen in: Drugs & Aging | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Many studies focus on interventions that reduce the processes that lead to adverse drug events (ADEs), such as inappropriate or high-risk prescribing, without assessing whether they result in a reduction in ADEs or associated adverse health outcomes.

Objectives

Our objective was to systematically review interventions to reduce the incidence of ADEs measured by health outcomes in older patients in primary care settings.

Methods

The review included randomised controlled trials, controlled clinical trials, controlled before and after studies, interrupted time series studies and cohort studies conducted in the community care setting. Older patients (aged ≥ 65 years) receiving medical treatment in primary care were included. Interventions were aimed at reducing adverse health outcomes associated with ADEs in older patients. Risk of bias was assessed using the Cochrane Collaboration’s tool. Outcomes were measured by reductions in hospitalisation, emergency department (ED) visits, mortality and improvements in quality of life (QoL), mental health and physical function. Fixed and random-effects models were used to calculate pooled effect estimates comparing interventions and control groups for the outcomes, where feasible.

Results

The literature search identified 1566 abstracts, seven of which were included in the systematic review. The interventions for reducing ADEs included prescription or medication reviews by a pharmacist (n = 4), primary care physician (n = 1) or research team (n = 1), and an educational intervention (n = 1) for nursing staff to improve the recognition of potentially harmful medications and corresponding ADEs. Meta-analysis found no statistically significant benefit from any interventions on hospitalisation, ED visits, mortality, QoL or mental health and physical function.

Conclusions

No significant benefit was gained from any of the interventions in terms of the outcomes considered. New approaches are required to reduce ADEs in older adults.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Nebeker J, Barach P, Samore M. Clarifying adverse drug events: a clinician’s guide to terminology, documentation, and reporting. Ann Intern Med. 2004;140(10):795–801.CrossRef Nebeker J, Barach P, Samore M. Clarifying adverse drug events: a clinician’s guide to terminology, documentation, and reporting. Ann Intern Med. 2004;140(10):795–801.CrossRef
3.
Zurück zum Zitat Beijer J, de Blaey C. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002;23(2):46–54 (PMID:12061133).CrossRef Beijer J, de Blaey C. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002;23(2):46–54 (PMID:12061133).CrossRef
4.
Zurück zum Zitat Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ. 2004;329:15.CrossRef Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ. 2004;329:15.CrossRef
6.
Zurück zum Zitat Hohl C, Dankoff J, Colacone A, Afilalo M. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med. 2001;38(6):666–71.CrossRef Hohl C, Dankoff J, Colacone A, Afilalo M. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med. 2001;38(6):666–71.CrossRef
7.
Zurück zum Zitat Laroche M, Charmes J, Nouaille Y, Picard N, Merle L. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol. 2007;63:177–86.CrossRef Laroche M, Charmes J, Nouaille Y, Picard N, Merle L. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol. 2007;63:177–86.CrossRef
8.
Zurück zum Zitat Onder G, Petrovic M, Tangiisuran B, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Arch Intern Med. 2010;170:1142–8.CrossRef Onder G, Petrovic M, Tangiisuran B, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Arch Intern Med. 2010;170:1142–8.CrossRef
10.
Zurück zum Zitat Spinewine A, Fialova D, Byrne S. The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Ageing. 2012;29:495–510.CrossRef Spinewine A, Fialova D, Byrne S. The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Ageing. 2012;29:495–510.CrossRef
12.
Zurück zum Zitat Higgins JPT, Sterne JAC, Savović J et al. A revised tool for assessing risk of bias in randomized trials In: Chandler J, McKenzie J, Boutron I, Welch V (editors). Cochrane Methods. Cochrane Database of Systematic Reviews 2016; Issue 10 (Suppl 1). dx.doi.org/https://doi.org/10.1002/14651858.cd201601. Higgins JPT, Sterne JAC, Savović J et al. A revised tool for assessing risk of bias in randomized trials In: Chandler J, McKenzie J, Boutron I, Welch V (editors). Cochrane Methods. Cochrane Database of Systematic Reviews 2016; Issue 10 (Suppl 1). dx.doi.org/https://​doi.​org/​10.​1002/​14651858.​cd201601.​
13.
Zurück zum Zitat Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46:72–83.CrossRef Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46:72–83.CrossRef
14.
Zurück zum Zitat American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012). American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–31.CrossRef American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012). American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–31.CrossRef
15.
Zurück zum Zitat Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45:1045–51.CrossRef Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45:1045–51.CrossRef
16.
Zurück zum Zitat Pitkala K, Juola A, Kautiainen H, et al. Education to reduce potentially harmful medication use among residents of assisted living facilities: a randomized controlled trial. JAMDA. 2014;15:892–8.PubMed Pitkala K, Juola A, Kautiainen H, et al. Education to reduce potentially harmful medication use among residents of assisted living facilities: a randomized controlled trial. JAMDA. 2014;15:892–8.PubMed
17.
Zurück zum Zitat Frankenthal D, Lerman Y, Kalendaryev E, Lerman Y. Intervention with the Screening tool of older persons potentially inappropriate prescriptions/Screening Tool to Alert Doctors to right Treatment Criteria in elderly residents of a chronic geriatric facility: a randomized clinical trial. JAGS. 2014;62:1658–65.CrossRef Frankenthal D, Lerman Y, Kalendaryev E, Lerman Y. Intervention with the Screening tool of older persons potentially inappropriate prescriptions/Screening Tool to Alert Doctors to right Treatment Criteria in elderly residents of a chronic geriatric facility: a randomized clinical trial. JAGS. 2014;62:1658–65.CrossRef
19.
Zurück zum Zitat Touchette D, Masica A, Dolor R, et al. Safety-focussed medication therapy management: a randomized controlled trial. J Am Pharm Assoc. 2012;52:603–12.CrossRef Touchette D, Masica A, Dolor R, et al. Safety-focussed medication therapy management: a randomized controlled trial. J Am Pharm Assoc. 2012;52:603–12.CrossRef
20.
Zurück zum Zitat Hanlon J, Weinberger M, Samsa G, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100:428–37.CrossRef Hanlon J, Weinberger M, Samsa G, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100:428–37.CrossRef
21.
Zurück zum Zitat Yeh Y, Liu C, Peng L, Lin M, Chen L. Potential benefits of reducing medication-related anticholinergic burden for demented older adults: a prospective cohort study. Geriatr Gerontol Int. 2013;13:694–700.CrossRef Yeh Y, Liu C, Peng L, Lin M, Chen L. Potential benefits of reducing medication-related anticholinergic burden for demented older adults: a prospective cohort study. Geriatr Gerontol Int. 2013;13:694–700.CrossRef
22.
Zurück zum Zitat Olsson I, Runnamo R, Engfeldt P. Drug treatment in the elderly: an intervention in primary care to enhance prescription quality and quality of life. Scan J Prim Health C. 2012;30:3–9.CrossRef Olsson I, Runnamo R, Engfeldt P. Drug treatment in the elderly: an intervention in primary care to enhance prescription quality and quality of life. Scan J Prim Health C. 2012;30:3–9.CrossRef
23.
Zurück zum Zitat Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R. Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ. 2002;324:1417–21.CrossRef Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R. Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ. 2002;324:1417–21.CrossRef
24.
Zurück zum Zitat Formica D, Sultana J, Cutroneo P, et al. The economic burden of preventable adverse drug reactions: a systematic review of observational studies. Expert Opin Drug Saf. 2018;17(7):681–95.CrossRef Formica D, Sultana J, Cutroneo P, et al. The economic burden of preventable adverse drug reactions: a systematic review of observational studies. Expert Opin Drug Saf. 2018;17(7):681–95.CrossRef
25.
Zurück zum Zitat Kucukarslan S, Peters M, Mlynarek M, Naafziger D. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163:2014–8.CrossRef Kucukarslan S, Peters M, Mlynarek M, Naafziger D. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163:2014–8.CrossRef
27.
Zurück zum Zitat Avery A, Rodgers S, Cantrill J, et al. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet. 2012;379(9823):1210–9.CrossRef Avery A, Rodgers S, Cantrill J, et al. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet. 2012;379(9823):1210–9.CrossRef
Metadaten
Titel
Interventions to Reduce Adverse Drug Event-Related Outcomes in Older Adults: A Systematic Review and Meta-analysis
verfasst von
Sarah Tecklenborg
Catherine Byrne
Caitriona Cahir
Lamorna Brown
Kathleen Bennett
Publikationsdatum
01.02.2020
Verlag
Springer International Publishing
Erschienen in
Drugs & Aging / Ausgabe 2/2020
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-019-00738-w

Weitere Artikel der Ausgabe 2/2020

Drugs & Aging 2/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.